Earnings Call · Q2 FY2024·2024-08-03

Q2 24EPS +13.51%·Rev n/aQ1 24EPS +5.88%·Rev n/aQ4 23EPS +2.63%·Rev n/aQ3 23EPS +16.22%·Rev n/a⚠ consensus missing

IRADIMED CORP IRMD

Roger Susi — Chief Executive Officer

Matt Garner — Chief Financial Officer

−1.2%1d on move date+0.2% vs SPY3d−5.2%5d−7.5%

Research tier

Behavioral profile computed for 2 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more IRMD calls or request research access.

More IRMD calls Browse calls Request research access